Covid 19 Research using Clinical Trials (Home Page)
Report for D001835: Body Weight NIH
(Synonyms: Body W, Body Wei, Body Weig, Body Weigh, Body Weight)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (7)
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug687 | Clofazimine Wiki | 0.71 |
| drug1187 | Graded exercise test Wiki | 0.71 |
| drug1572 | Lifestyle App Wiki | 0.71 |
| drug892 | Dietary intake, body composition, lifestyle, and CVD risk factors Wiki | 0.71 |
| drug690 | Cloth Face Mask Wiki | 0.71 |
| drug1802 | N-95 Respirator Wiki | 0.71 |
| drug1437 | Interferon beta-1b Wiki | 0.50 |
Correlated MeSH Terms (2)
| Name (Synonyms) | Correlation | |
|---|---|---|
| D000073496 | Frailty NIH | 0.29 |
| D003920 | Diabetes Mellitus, NIH | 0.17 |
There are 2 clinical trials
Clinical Trials
1 Differences in Dietary Intake, Body Composition, Lifestyle and Various Cardiovascular Diseases Risk Factors Among Healthy and Active Vegetrians and Non Vegetarians
There is objective need to evaluate the differences in dietary intake (DI), body composition (BC), lifestyle (LS) and cardiovascular diseases (CVD) risk factors between healthy and active vegetarinas (VEG) and non vegetarians (non VEG) and references (according to gender). The aim of this cross-sectional study for investigators is to document the potential differences in DI (non adjusted and adjusted), BC, LS and CVD risk factors between healthy and active VEG and non VEG, aged from 18 to 80 years, and to evaluated correlation between DI variables and CVD risk factors. The study during the COVID-19 pandemic period will be self-reported. As variables the investigators will include the dietary intake, BC (body height, body weight, body mass index (BMI), body fat percentage (BF %)), lifestyle status (physical activity, daily seating, hygiene of sleep, socio-economic status, and motive for practicing chosen diet). The investigators will also record their maximum (lifetime) body weight, lipids (total-cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides) and blood pressure (BP) status. The investigators hypothesis are: (H1): There are differences in DI and quality of the diet (compared with references). (H2): There are differences in BC between the VEG in non VEG (according to gender). (H3): The are no differences between in CVD risk factors between the VEG and non VEG (according to gender). (H4): The are no differences in the effect of two intervals of time restricted feeding (i.e., 8-12 hours vs. 12-16 hours) within dietary pattern (according to gender).
NCT04379622 Diet, Healthy Body Weight Time Restricted Feeding Sleep Cardiovascular Risk Factor Motivation Other: Dietary intake, body composition, lifestyle, and CVD risk factors MeSH:Body Weight
Primary Outcomes
Description: Body weight measured with medically approved weighing scale
Measure: Body weight status Time: Cross-sectional (April-June 2020)Description: Height status measured with medically approved weighing scale with height rod
Measure: Height status Time: Cross-sectional (April-June 2020)Description: Measured weight and height will be combined to report BMI in kg/m2
Measure: Body mass index (BMI) status Time: Cross-sectional (April-June 2020)Description: Fat tissue mass measured with bioimpedance analysis
Measure: Fat tissue mass status Time: Cross-sectional (April-June 2020)Description: Dietary intake measured by food frequency questionnaire
Measure: Dietary intake status Time: Cross-sectional (May-June 2020)Description: Serum total cholesterol concentration
Measure: Serum cholesterol status Time: Cross-sectional (May 2019-June 2020)Description: Serum concentration of oxidized LDL-cholesterol
Measure: Oxidized Low Density Lipoprotein (LDL)-cholesterol status Time: Cross-sectional (May 2019-June 2020)Description: Serum HDL cholesterol concentration
Measure: Serum HDL cholesterol status Time: Cross-sectional (May 2019-June 2020)Description: Serum triglyceride concentrations
Measure: Serum triglyceride status Time: Cross-sectional (May 2019-June 2020)Description: Blood pressure status (systolic and diastolic)
Measure: Blood pressure status Time: Cross-sectional (May 2019-June 2020)Secondary Outcomes
Description: Socio-economic and demographic status measured using Nutritional behaviours of adults Slovenians from the point of of health prevention questionnaire (Slovenian National Institute of Health)
Measure: Socio-economic and demographic status Time: Cross-sectional (May-June 2020)Description: Physical activity status measured by The International Physical Activity Questionnaires
Measure: Physical activity status Time: Cross-sectional (May-June 2020)Description: Sleep status measured with The Pittsburgh Sleep Quality Index
Measure: Sleep status Time: Cross-sectional (May-June 2020)Description: Motives for dietary pattern status measured by investigators questionnaire
Measure: Motives for dietary pattern status Time: Cross-sectional (May-June 2020)2 Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes: A Pilot Study
The study team want to see if changes in lifestyle and behaviors and self-monitoring of diet and physical activity in older adults who have type 2 Diabetes (T2D) may help to prevent or reduce frailty. Frailty occurs in older adults and leads people to have falls, become disabled, require nursing home placement, and have increased risk of death. T2D is one of the major risk factors for frailty. T2D is a significant problem in older adults and is known to increase the risk of future frailty.
NCT04440449 Frailty Weight, Body Type 2 Diabetes Behavioral: Lifestyle App MeSH:Diabetes Mellitus Frailty Body Weight
HPO:Diabetes mellitus
Primary Outcomes
Description: Change in frailty measured on a scale using a frailty score (0, 1, 2, 3, 4,or 5), with higher scores out of 5 representing greater frailty. Assessments used for scoring include 1) self reported weight loss, 2) self-reported exhaustion 3) low physical activity based on the Minnesota Leisure Time Physical Activity Questionnaire (MLTPAQ) 4) Handgrip strength 5) 10 foot walk pace
Measure: Frailty Scale Time: Baseline to 6 months
Secondary Outcomes
Description: Change in HbA1c measured over the study period
Measure: Glycated hemoglobin (HbA1c) Time: Baseline to 6 months
Description: For PROMIS measures, higher scores equals more of the concept being measured (e.g., more Fatigue, more Physical Function). Thus a score of 60 is one standard deviation above the average referenced population. This could be a desirable or undesirable outcome, depending upon the concept being measured.
Measure: Patient-Reported Outcomes Measurement Information System (PROMIS) Time: Baseline to 6 months
Description: The study team will administer the Short Physical Performance Battery (SPPB)69 to assess three lower extremity tasks; 1) standing balance (ability to stand with the feet together in side-by-side, semi-and full-tandem positions for 10 seconds each); 2) a 4-meter walk to assess usual gait speed; 3) time to complete 5 repeated chair stand. Each of the 3 performance measures is assigned a score ranging from 0 (inability to perform the task) to 4 (the highest level of performance) and summed to create a score ranging from 0 to 12 (best). The SPPB is sensitive to change over time
Measure: Short Physical Performance Battery (SPPB) Time: Baseline to 6 months
HPO Nodes
Primary Outcomes
Description: Change in frailty measured on a scale using a frailty score (0, 1, 2, 3, 4,or 5), with higher scores out of 5 representing greater frailty. Assessments used for scoring include 1) self reported weight loss, 2) self-reported exhaustion 3) low physical activity based on the Minnesota Leisure Time Physical Activity Questionnaire (MLTPAQ) 4) Handgrip strength 5) 10 foot walk pace
Measure: Frailty Scale Time: Baseline to 6 monthsSecondary Outcomes
Description: Change in HbA1c measured over the study period
Measure: Glycated hemoglobin (HbA1c) Time: Baseline to 6 monthsDescription: For PROMIS measures, higher scores equals more of the concept being measured (e.g., more Fatigue, more Physical Function). Thus a score of 60 is one standard deviation above the average referenced population. This could be a desirable or undesirable outcome, depending upon the concept being measured.
Measure: Patient-Reported Outcomes Measurement Information System (PROMIS) Time: Baseline to 6 monthsDescription: The study team will administer the Short Physical Performance Battery (SPPB)69 to assess three lower extremity tasks; 1) standing balance (ability to stand with the feet together in side-by-side, semi-and full-tandem positions for 10 seconds each); 2) a 4-meter walk to assess usual gait speed; 3) time to complete 5 repeated chair stand. Each of the 3 performance measures is assigned a score ranging from 0 (inability to perform the task) to 4 (the highest level of performance) and summed to create a score ranging from 0 to 12 (best). The SPPB is sensitive to change over time
Measure: Short Physical Performance Battery (SPPB) Time: Baseline to 6 months